SEC Form 4/A · accession 0001209191-16-127490
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Nassim Usman
Officer — President and CEO · Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 13, 2016 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | — | Jun 9, 2016 | J | 0 | A | — | — | Common Stock | 0 | 0 | D |
Explanation of responses
- F1On June 13, 2016, a Form 4 was mistakenly filed reporting an award of 7,500 stock options on June 9, 2016, that did not in fact occur.
Remarks
This amendment to Reporting Person's Form 4 filed on June 13, 2016, is being filed to correct errors on the Form 4 as originally filed. A stock option award that did not occur was inadvertently reported. That award is hereby deleted and no other transactions by the Reporting Person occurred on June 13, 2016.